等待开盘 07-22 09:30:00 美东时间
+0.060
+0.50%
Rithm Capital (NYSE:RITM) has been analyzed by 5 analysts in the last three mon...
07-16 02:01
UBS analyst Douglas Harter maintains Rithm Capital (NYSE:RITM) with a Buy and raises the price target from $13 to $14.
07-15 22:25
Rithm Capital Corp.PD (RITM.PR.D) declares $0.4375/share quarterly dividend. Payable Aug. 15; for shareholders of record Aug. 1; ex-div Aug. 1. See RITM.PR.D Dividend Scorecard, Yield Chart, & Dividen...
06-19 16:46
Rithm Capital (NYSE:RITM) declares $0.25/share quarterly dividend, in line with previous. Forward yield 8.93% Payable July 31; for shareholders of record June 30; ex-div June 30. See RITM Dividend Sco...
06-19 04:18
Rithm Capital (NYSE:RITM) has priced its previously announced offering of $500M aggregate principal amount of 8% senior unsecured notes due 2030. The company intends to use a portion of the net procee...
06-18 04:30
Rithm Capital (NYSE:RITM) plans to offer $500 million aggregate principal amount of senior unsecured notes due 2030. The company intends to use a portion of the net proceeds from this offering to rede...
06-16 19:39
Rithm Capital Corp. (NYSE:RITM, "Rithm" or the "Company"))) announced today that it plans to offer $500 million aggregate principal amount of senior unsecured notes due 2030 (the "notes"). The Company intends to use a
06-16 19:32
There’s a lot to be optimistic about in the Real Estate sector as 2 analysts ju...
06-09 20:50
潜在涨幅300.0%!HC Wainwright & Co.:Armata Pharmaceuticals获机构升目标价至9美元,维持"买入"评级
05-21 16:44
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1131517965561573377.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.:维持Armata Pharmaceuticals(ARMP)"买入"评级,目标价从7美元升至9美元</p> <p>• 瑞银:维持爱芬奇(ANF)"买入"评级,目标价从115美
05-20 09:28